Davis Investment Partners LLC Decreases Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Davis Investment Partners LLC trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 427 shares of the medical equipment provider’s stock after selling 29 shares during the period. Davis Investment Partners LLC’s holdings in Intuitive Surgical were worth $234,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also made changes to their positions in ISRG. Mirador Capital Partners LP increased its stake in Intuitive Surgical by 1.4% in the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after buying an additional 50 shares during the period. Exome Asset Management LLC increased its stake in shares of Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after purchasing an additional 1,069 shares in the last quarter. Consolidated Planning Corp lifted its holdings in Intuitive Surgical by 17.4% in the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after purchasing an additional 1,198 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its position in shares of Intuitive Surgical by 73.2% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 270,029 shares of the medical equipment provider’s stock valued at $132,657,000 after buying an additional 114,149 shares during the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund increased its stake in shares of Intuitive Surgical by 617.1% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after acquiring an additional 76,649 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, SVP Mark Brosius sold 2,128 shares of the firm’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,095,920.00. Following the completion of the transaction, the senior vice president now directly owns 273 shares of the company’s stock, valued at $140,595. This trade represents a 88.63 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 48,190 shares of company stock valued at $25,012,927. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Down 1.4 %

Shares of NASDAQ ISRG traded down $7.72 during mid-day trading on Monday, hitting $539.75. 1,387,774 shares of the company traded hands, compared to its average volume of 1,350,754. Intuitive Surgical, Inc. has a 1 year low of $355.17 and a 1 year high of $556.23. The stock has a market capitalization of $192.25 billion, a price-to-earnings ratio of 86.78, a PEG ratio of 5.31 and a beta of 1.39. The business has a 50 day moving average of $535.93 and a two-hundred day moving average of $495.17.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Wells Fargo & Company boosted their price objective on shares of Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, December 11th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Mizuho upped their target price on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Finally, The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.